Global Helicobacter Pylori Diagnostics Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
According to APO Research, The global Helicobacter Pylori Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Helicobacter Pylori Diagnostics include Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics and Quidel, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Helicobacter Pylori Diagnostics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Helicobacter Pylori Diagnostics, also provides the value of main regions and countries. Of the upcoming market potential for Helicobacter Pylori Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Helicobacter Pylori Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Helicobacter Pylori Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Helicobacter Pylori Diagnostics company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Helicobacter Pylori Diagnostics segment by Company
1. To analyze and research the global Helicobacter Pylori Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Helicobacter Pylori Diagnostics key companies, revenue, market share, and recent developments.
3. To split the Helicobacter Pylori Diagnostics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Helicobacter Pylori Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Helicobacter Pylori Diagnostics significant trends, drivers, influence factors in global and regions.
6. To analyze Helicobacter Pylori Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Helicobacter Pylori Diagnostics industry.
Chapter 3: Detailed analysis of Helicobacter Pylori Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Helicobacter Pylori Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Helicobacter Pylori Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.
According to APO Research, The global Helicobacter Pylori Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Helicobacter Pylori Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Helicobacter Pylori Diagnostics include Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics and Quidel, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Helicobacter Pylori Diagnostics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Helicobacter Pylori Diagnostics, also provides the value of main regions and countries. Of the upcoming market potential for Helicobacter Pylori Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Helicobacter Pylori Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Helicobacter Pylori Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Helicobacter Pylori Diagnostics company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Helicobacter Pylori Diagnostics segment by Company
- Sekisui Diagnostics
- F. Hoffmann-La Roche
- Medline Industries
- Meridian Bioscience
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Alpha Laboratories
- EKF Diagnostics
- Quidel
- Halyard Health
- Cardinal Health
- Beckman Coulter
- Agilent Technologies
- Coris BioConcept
- Invasive Techniques
- Non-invasive Techniques
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Helicobacter Pylori Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Helicobacter Pylori Diagnostics key companies, revenue, market share, and recent developments.
3. To split the Helicobacter Pylori Diagnostics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Helicobacter Pylori Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Helicobacter Pylori Diagnostics significant trends, drivers, influence factors in global and regions.
6. To analyze Helicobacter Pylori Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Helicobacter Pylori Diagnostics industry.
Chapter 3: Detailed analysis of Helicobacter Pylori Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Helicobacter Pylori Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Helicobacter Pylori Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Helicobacter Pylori Diagnostics Market Size, 2019 VS 2023 VS 2030
1.3 Global Helicobacter Pylori Diagnostics Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HELICOBACTER PYLORI DIAGNOSTICS MARKET DYNAMICS
2.1 Helicobacter Pylori Diagnostics Industry Trends
2.2 Helicobacter Pylori Diagnostics Industry Drivers
2.3 Helicobacter Pylori Diagnostics Industry Opportunities and Challenges
2.4 Helicobacter Pylori Diagnostics Industry Restraints
3 HELICOBACTER PYLORI DIAGNOSTICS MARKET BY COMPANY
3.1 Global Helicobacter Pylori Diagnostics Company Revenue Ranking in 2023
3.2 Global Helicobacter Pylori Diagnostics Revenue by Company (2019-2024)
3.3 Global Helicobacter Pylori Diagnostics Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Helicobacter Pylori Diagnostics Company Manufacturing Base & Headquarters
3.5 Global Helicobacter Pylori Diagnostics Company, Product Type & Application
3.6 Global Helicobacter Pylori Diagnostics Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Helicobacter Pylori Diagnostics Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Helicobacter Pylori Diagnostics Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 HELICOBACTER PYLORI DIAGNOSTICS MARKET BY TYPE
4.1 Helicobacter Pylori Diagnostics Type Introduction
4.1.1 Invasive Techniques
4.1.2 Non-invasive Techniques
4.2 Global Helicobacter Pylori Diagnostics Sales Value by Type
4.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Type (2019-2030)
4.2.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2019-2030)
5 HELICOBACTER PYLORI DIAGNOSTICS MARKET BY APPLICATION
5.1 Helicobacter Pylori Diagnostics Application Introduction
5.1.1 Hospitals and Clinics
5.1.2 Diagnostic Laboratories
5.1.3 Others
5.2 Global Helicobacter Pylori Diagnostics Sales Value by Application
5.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Application (2019-2030)
5.2.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2019-2030)
6 HELICOBACTER PYLORI DIAGNOSTICS MARKET BY REGION
6.1 Global Helicobacter Pylori Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Helicobacter Pylori Diagnostics Sales Value by Region (2019-2030)
6.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Region: 2019-2024
6.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Helicobacter Pylori Diagnostics Sales Value (2019-2030)
6.3.2 North America Helicobacter Pylori Diagnostics Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Helicobacter Pylori Diagnostics Sales Value (2019-2030)
6.4.2 Europe Helicobacter Pylori Diagnostics Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Helicobacter Pylori Diagnostics Sales Value (2019-2030)
6.5.2 Asia-Pacific Helicobacter Pylori Diagnostics Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Helicobacter Pylori Diagnostics Sales Value (2019-2030)
6.6.2 Latin America Helicobacter Pylori Diagnostics Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Helicobacter Pylori Diagnostics Sales Value (2019-2030)
6.7.2 Middle East & Africa Helicobacter Pylori Diagnostics Sales Value Share by Country, 2023 VS 2030
7 HELICOBACTER PYLORI DIAGNOSTICS MARKET BY COUNTRY
7.1 Global Helicobacter Pylori Diagnostics Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Helicobacter Pylori Diagnostics Sales Value by Country (2019-2030)
7.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Country (2019-2024)
7.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.3.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.4.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.5.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.6.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.7.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.8.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.9.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.10.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.11.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.12.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.13.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.14.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.15.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.16.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.17.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.18.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.19.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.20.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.21.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Sekisui Diagnostics
8.1.1 Sekisui Diagnostics Comapny Information
8.1.2 Sekisui Diagnostics Business Overview
8.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
8.1.5 Sekisui Diagnostics Recent Developments
8.2 F. Hoffmann-La Roche
8.2.1 F. Hoffmann-La Roche Comapny Information
8.2.2 F. Hoffmann-La Roche Business Overview
8.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
8.2.5 F. Hoffmann-La Roche Recent Developments
8.3 Medline Industries
8.3.1 Medline Industries Comapny Information
8.3.2 Medline Industries Business Overview
8.3.3 Medline Industries Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.3.4 Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
8.3.5 Medline Industries Recent Developments
8.4 Meridian Bioscience
8.4.1 Meridian Bioscience Comapny Information
8.4.2 Meridian Bioscience Business Overview
8.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
8.4.5 Meridian Bioscience Recent Developments
8.5 Bio-Rad Laboratories
8.5.1 Bio-Rad Laboratories Comapny Information
8.5.2 Bio-Rad Laboratories Business Overview
8.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
8.5.5 Bio-Rad Laboratories Recent Developments
8.6 Thermo Fisher Scientific
8.6.1 Thermo Fisher Scientific Comapny Information
8.6.2 Thermo Fisher Scientific Business Overview
8.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
8.6.5 Thermo Fisher Scientific Recent Developments
8.7 Alpha Laboratories
8.7.1 Alpha Laboratories Comapny Information
8.7.2 Alpha Laboratories Business Overview
8.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
8.7.5 Alpha Laboratories Recent Developments
8.8 EKF Diagnostics
8.8.1 EKF Diagnostics Comapny Information
8.8.2 EKF Diagnostics Business Overview
8.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
8.8.5 EKF Diagnostics Recent Developments
8.9 Quidel
8.9.1 Quidel Comapny Information
8.9.2 Quidel Business Overview
8.9.3 Quidel Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.9.4 Quidel Helicobacter Pylori Diagnostics Product Portfolio
8.9.5 Quidel Recent Developments
8.10 Halyard Health
8.10.1 Halyard Health Comapny Information
8.10.2 Halyard Health Business Overview
8.10.3 Halyard Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.10.4 Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
8.10.5 Halyard Health Recent Developments
8.11 Cardinal Health
8.11.1 Cardinal Health Comapny Information
8.11.2 Cardinal Health Business Overview
8.11.3 Cardinal Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.11.4 Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
8.11.5 Cardinal Health Recent Developments
8.12 Beckman Coulter
8.12.1 Beckman Coulter Comapny Information
8.12.2 Beckman Coulter Business Overview
8.12.3 Beckman Coulter Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
8.12.5 Beckman Coulter Recent Developments
8.13 Agilent Technologies
8.13.1 Agilent Technologies Comapny Information
8.13.2 Agilent Technologies Business Overview
8.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
8.13.5 Agilent Technologies Recent Developments
8.14 Coris BioConcept
8.14.1 Coris BioConcept Comapny Information
8.14.2 Coris BioConcept Business Overview
8.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
8.14.5 Coris BioConcept Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
1.1 Product Definition
1.2 Global Helicobacter Pylori Diagnostics Market Size, 2019 VS 2023 VS 2030
1.3 Global Helicobacter Pylori Diagnostics Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HELICOBACTER PYLORI DIAGNOSTICS MARKET DYNAMICS
2.1 Helicobacter Pylori Diagnostics Industry Trends
2.2 Helicobacter Pylori Diagnostics Industry Drivers
2.3 Helicobacter Pylori Diagnostics Industry Opportunities and Challenges
2.4 Helicobacter Pylori Diagnostics Industry Restraints
3 HELICOBACTER PYLORI DIAGNOSTICS MARKET BY COMPANY
3.1 Global Helicobacter Pylori Diagnostics Company Revenue Ranking in 2023
3.2 Global Helicobacter Pylori Diagnostics Revenue by Company (2019-2024)
3.3 Global Helicobacter Pylori Diagnostics Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Helicobacter Pylori Diagnostics Company Manufacturing Base & Headquarters
3.5 Global Helicobacter Pylori Diagnostics Company, Product Type & Application
3.6 Global Helicobacter Pylori Diagnostics Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Helicobacter Pylori Diagnostics Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Helicobacter Pylori Diagnostics Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 HELICOBACTER PYLORI DIAGNOSTICS MARKET BY TYPE
4.1 Helicobacter Pylori Diagnostics Type Introduction
4.1.1 Invasive Techniques
4.1.2 Non-invasive Techniques
4.2 Global Helicobacter Pylori Diagnostics Sales Value by Type
4.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Type (2019-2030)
4.2.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2019-2030)
5 HELICOBACTER PYLORI DIAGNOSTICS MARKET BY APPLICATION
5.1 Helicobacter Pylori Diagnostics Application Introduction
5.1.1 Hospitals and Clinics
5.1.2 Diagnostic Laboratories
5.1.3 Others
5.2 Global Helicobacter Pylori Diagnostics Sales Value by Application
5.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Application (2019-2030)
5.2.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2019-2030)
6 HELICOBACTER PYLORI DIAGNOSTICS MARKET BY REGION
6.1 Global Helicobacter Pylori Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Helicobacter Pylori Diagnostics Sales Value by Region (2019-2030)
6.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Region: 2019-2024
6.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Helicobacter Pylori Diagnostics Sales Value (2019-2030)
6.3.2 North America Helicobacter Pylori Diagnostics Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Helicobacter Pylori Diagnostics Sales Value (2019-2030)
6.4.2 Europe Helicobacter Pylori Diagnostics Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Helicobacter Pylori Diagnostics Sales Value (2019-2030)
6.5.2 Asia-Pacific Helicobacter Pylori Diagnostics Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Helicobacter Pylori Diagnostics Sales Value (2019-2030)
6.6.2 Latin America Helicobacter Pylori Diagnostics Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Helicobacter Pylori Diagnostics Sales Value (2019-2030)
6.7.2 Middle East & Africa Helicobacter Pylori Diagnostics Sales Value Share by Country, 2023 VS 2030
7 HELICOBACTER PYLORI DIAGNOSTICS MARKET BY COUNTRY
7.1 Global Helicobacter Pylori Diagnostics Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Helicobacter Pylori Diagnostics Sales Value by Country (2019-2030)
7.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Country (2019-2024)
7.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.3.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.4.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.5.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.6.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.7.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.8.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.9.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.10.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.11.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.12.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.13.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.14.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.15.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.16.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.17.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.18.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.19.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.20.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030)
7.21.2 Global Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Sekisui Diagnostics
8.1.1 Sekisui Diagnostics Comapny Information
8.1.2 Sekisui Diagnostics Business Overview
8.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
8.1.5 Sekisui Diagnostics Recent Developments
8.2 F. Hoffmann-La Roche
8.2.1 F. Hoffmann-La Roche Comapny Information
8.2.2 F. Hoffmann-La Roche Business Overview
8.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
8.2.5 F. Hoffmann-La Roche Recent Developments
8.3 Medline Industries
8.3.1 Medline Industries Comapny Information
8.3.2 Medline Industries Business Overview
8.3.3 Medline Industries Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.3.4 Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
8.3.5 Medline Industries Recent Developments
8.4 Meridian Bioscience
8.4.1 Meridian Bioscience Comapny Information
8.4.2 Meridian Bioscience Business Overview
8.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
8.4.5 Meridian Bioscience Recent Developments
8.5 Bio-Rad Laboratories
8.5.1 Bio-Rad Laboratories Comapny Information
8.5.2 Bio-Rad Laboratories Business Overview
8.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
8.5.5 Bio-Rad Laboratories Recent Developments
8.6 Thermo Fisher Scientific
8.6.1 Thermo Fisher Scientific Comapny Information
8.6.2 Thermo Fisher Scientific Business Overview
8.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
8.6.5 Thermo Fisher Scientific Recent Developments
8.7 Alpha Laboratories
8.7.1 Alpha Laboratories Comapny Information
8.7.2 Alpha Laboratories Business Overview
8.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
8.7.5 Alpha Laboratories Recent Developments
8.8 EKF Diagnostics
8.8.1 EKF Diagnostics Comapny Information
8.8.2 EKF Diagnostics Business Overview
8.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
8.8.5 EKF Diagnostics Recent Developments
8.9 Quidel
8.9.1 Quidel Comapny Information
8.9.2 Quidel Business Overview
8.9.3 Quidel Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.9.4 Quidel Helicobacter Pylori Diagnostics Product Portfolio
8.9.5 Quidel Recent Developments
8.10 Halyard Health
8.10.1 Halyard Health Comapny Information
8.10.2 Halyard Health Business Overview
8.10.3 Halyard Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.10.4 Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
8.10.5 Halyard Health Recent Developments
8.11 Cardinal Health
8.11.1 Cardinal Health Comapny Information
8.11.2 Cardinal Health Business Overview
8.11.3 Cardinal Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.11.4 Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
8.11.5 Cardinal Health Recent Developments
8.12 Beckman Coulter
8.12.1 Beckman Coulter Comapny Information
8.12.2 Beckman Coulter Business Overview
8.12.3 Beckman Coulter Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
8.12.5 Beckman Coulter Recent Developments
8.13 Agilent Technologies
8.13.1 Agilent Technologies Comapny Information
8.13.2 Agilent Technologies Business Overview
8.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
8.13.5 Agilent Technologies Recent Developments
8.14 Coris BioConcept
8.14.1 Coris BioConcept Comapny Information
8.14.2 Coris BioConcept Business Overview
8.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Revenue and Gross Margin (2019-2024)
8.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
8.14.5 Coris BioConcept Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
LIST OF TABLES
Table 1. Helicobacter Pylori Diagnostics Industry Trends
Table 2. Helicobacter Pylori Diagnostics Industry Drivers
Table 3. Helicobacter Pylori Diagnostics Industry Opportunities and Challenges
Table 4. Helicobacter Pylori Diagnostics Industry Restraints
Table 5. Global Helicobacter Pylori Diagnostics Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Helicobacter Pylori Diagnostics Revenue Share by Company (2019-2024)
Table 7. Global Helicobacter Pylori Diagnostics Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Helicobacter Pylori Diagnostics Key Company Manufacturing Base & Headquarters
Table 9. Global Helicobacter Pylori Diagnostics Company, Product Type & Application
Table 10. Global Helicobacter Pylori Diagnostics Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Helicobacter Pylori Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Invasive Techniques
Table 15. Major Companies of Non-invasive Techniques
Table 16. Global Helicobacter Pylori Diagnostics Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Helicobacter Pylori Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Helicobacter Pylori Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2019-2024)
Table 20. Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2025-2030)
Table 21. Major Companies of Hospitals and Clinics
Table 22. Major Companies of Diagnostic Laboratories
Table 23. Major Companies of Others
Table 24. Global Helicobacter Pylori Diagnostics Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Helicobacter Pylori Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 26. Global Helicobacter Pylori Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 27. Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2019-2024)
Table 28. Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2025-2030)
Table 29. Global Helicobacter Pylori Diagnostics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Helicobacter Pylori Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 31. Global Helicobacter Pylori Diagnostics Sales Value Share by Region (2019-2024)
Table 32. Global Helicobacter Pylori Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 33. Global Helicobacter Pylori Diagnostics Sales Value Share by Region (2025-2030)
Table 34. Global Helicobacter Pylori Diagnostics Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 35. Global Helicobacter Pylori Diagnostics Sales Value by Country (2019-2024) & (US$ Million)
Table 36. Global Helicobacter Pylori Diagnostics Sales Value Market Share by Country (2019-2024)
Table 37. Global Helicobacter Pylori Diagnostics Sales Value by Country (2025-2030) & (US$ Million)
Table 38. Global Helicobacter Pylori Diagnostics Sales Value Market Share by Country (2025-2030)
Table 39. Sekisui Diagnostics Company Information
Table 40. Sekisui Diagnostics Business Overview
Table 41. Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 42. Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
Table 43. Sekisui Diagnostics Recent Development
Table 44. F. Hoffmann-La Roche Company Information
Table 45. F. Hoffmann-La Roche Business Overview
Table 46. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 47. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
Table 48. F. Hoffmann-La Roche Recent Development
Table 49. Medline Industries Company Information
Table 50. Medline Industries Business Overview
Table 51. Medline Industries Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 52. Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
Table 53. Medline Industries Recent Development
Table 54. Meridian Bioscience Company Information
Table 55. Meridian Bioscience Business Overview
Table 56. Meridian Bioscience Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 57. Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
Table 58. Meridian Bioscience Recent Development
Table 59. Bio-Rad Laboratories Company Information
Table 60. Bio-Rad Laboratories Business Overview
Table 61. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 62. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
Table 63. Bio-Rad Laboratories Recent Development
Table 64. Thermo Fisher Scientific Company Information
Table 65. Thermo Fisher Scientific Business Overview
Table 66. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 67. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
Table 68. Thermo Fisher Scientific Recent Development
Table 69. Alpha Laboratories Company Information
Table 70. Alpha Laboratories Business Overview
Table 71. Alpha Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 72. Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
Table 73. Alpha Laboratories Recent Development
Table 74. EKF Diagnostics Company Information
Table 75. EKF Diagnostics Business Overview
Table 76. EKF Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 77. EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
Table 78. EKF Diagnostics Recent Development
Table 79. Quidel Company Information
Table 80. Quidel Business Overview
Table 81. Quidel Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 82. Quidel Helicobacter Pylori Diagnostics Product Portfolio
Table 83. Quidel Recent Development
Table 84. Halyard Health Company Information
Table 85. Halyard Health Business Overview
Table 86. Halyard Health Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 87. Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
Table 88. Halyard Health Recent Development
Table 89. Cardinal Health Company Information
Table 90. Cardinal Health Business Overview
Table 91. Cardinal Health Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
Table 93. Cardinal Health Recent Development
Table 94. Beckman Coulter Company Information
Table 95. Beckman Coulter Business Overview
Table 96. Beckman Coulter Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
Table 98. Beckman Coulter Recent Development
Table 99. Agilent Technologies Company Information
Table 100. Agilent Technologies Business Overview
Table 101. Agilent Technologies Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
Table 103. Agilent Technologies Recent Development
Table 104. Coris BioConcept Company Information
Table 105. Coris BioConcept Business Overview
Table 106. Coris BioConcept Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
Table 108. Coris BioConcept Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Authors List of This Report
Table 111. Secondary Sources
Table 112. Primary Sources
Table 1. Helicobacter Pylori Diagnostics Industry Trends
Table 2. Helicobacter Pylori Diagnostics Industry Drivers
Table 3. Helicobacter Pylori Diagnostics Industry Opportunities and Challenges
Table 4. Helicobacter Pylori Diagnostics Industry Restraints
Table 5. Global Helicobacter Pylori Diagnostics Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Helicobacter Pylori Diagnostics Revenue Share by Company (2019-2024)
Table 7. Global Helicobacter Pylori Diagnostics Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Helicobacter Pylori Diagnostics Key Company Manufacturing Base & Headquarters
Table 9. Global Helicobacter Pylori Diagnostics Company, Product Type & Application
Table 10. Global Helicobacter Pylori Diagnostics Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Helicobacter Pylori Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Invasive Techniques
Table 15. Major Companies of Non-invasive Techniques
Table 16. Global Helicobacter Pylori Diagnostics Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Helicobacter Pylori Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Helicobacter Pylori Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2019-2024)
Table 20. Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2025-2030)
Table 21. Major Companies of Hospitals and Clinics
Table 22. Major Companies of Diagnostic Laboratories
Table 23. Major Companies of Others
Table 24. Global Helicobacter Pylori Diagnostics Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Helicobacter Pylori Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 26. Global Helicobacter Pylori Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 27. Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2019-2024)
Table 28. Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2025-2030)
Table 29. Global Helicobacter Pylori Diagnostics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Helicobacter Pylori Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 31. Global Helicobacter Pylori Diagnostics Sales Value Share by Region (2019-2024)
Table 32. Global Helicobacter Pylori Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 33. Global Helicobacter Pylori Diagnostics Sales Value Share by Region (2025-2030)
Table 34. Global Helicobacter Pylori Diagnostics Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 35. Global Helicobacter Pylori Diagnostics Sales Value by Country (2019-2024) & (US$ Million)
Table 36. Global Helicobacter Pylori Diagnostics Sales Value Market Share by Country (2019-2024)
Table 37. Global Helicobacter Pylori Diagnostics Sales Value by Country (2025-2030) & (US$ Million)
Table 38. Global Helicobacter Pylori Diagnostics Sales Value Market Share by Country (2025-2030)
Table 39. Sekisui Diagnostics Company Information
Table 40. Sekisui Diagnostics Business Overview
Table 41. Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 42. Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
Table 43. Sekisui Diagnostics Recent Development
Table 44. F. Hoffmann-La Roche Company Information
Table 45. F. Hoffmann-La Roche Business Overview
Table 46. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 47. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
Table 48. F. Hoffmann-La Roche Recent Development
Table 49. Medline Industries Company Information
Table 50. Medline Industries Business Overview
Table 51. Medline Industries Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 52. Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
Table 53. Medline Industries Recent Development
Table 54. Meridian Bioscience Company Information
Table 55. Meridian Bioscience Business Overview
Table 56. Meridian Bioscience Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 57. Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
Table 58. Meridian Bioscience Recent Development
Table 59. Bio-Rad Laboratories Company Information
Table 60. Bio-Rad Laboratories Business Overview
Table 61. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 62. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
Table 63. Bio-Rad Laboratories Recent Development
Table 64. Thermo Fisher Scientific Company Information
Table 65. Thermo Fisher Scientific Business Overview
Table 66. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 67. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
Table 68. Thermo Fisher Scientific Recent Development
Table 69. Alpha Laboratories Company Information
Table 70. Alpha Laboratories Business Overview
Table 71. Alpha Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 72. Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
Table 73. Alpha Laboratories Recent Development
Table 74. EKF Diagnostics Company Information
Table 75. EKF Diagnostics Business Overview
Table 76. EKF Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 77. EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
Table 78. EKF Diagnostics Recent Development
Table 79. Quidel Company Information
Table 80. Quidel Business Overview
Table 81. Quidel Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 82. Quidel Helicobacter Pylori Diagnostics Product Portfolio
Table 83. Quidel Recent Development
Table 84. Halyard Health Company Information
Table 85. Halyard Health Business Overview
Table 86. Halyard Health Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 87. Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
Table 88. Halyard Health Recent Development
Table 89. Cardinal Health Company Information
Table 90. Cardinal Health Business Overview
Table 91. Cardinal Health Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
Table 93. Cardinal Health Recent Development
Table 94. Beckman Coulter Company Information
Table 95. Beckman Coulter Business Overview
Table 96. Beckman Coulter Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
Table 98. Beckman Coulter Recent Development
Table 99. Agilent Technologies Company Information
Table 100. Agilent Technologies Business Overview
Table 101. Agilent Technologies Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
Table 103. Agilent Technologies Recent Development
Table 104. Coris BioConcept Company Information
Table 105. Coris BioConcept Business Overview
Table 106. Coris BioConcept Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
Table 108. Coris BioConcept Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Authors List of This Report
Table 111. Secondary Sources
Table 112. Primary Sources
LIST OF FIGURES
Figure 1. Helicobacter Pylori Diagnostics Product Picture
Figure 2. Global Helicobacter Pylori Diagnostics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Helicobacter Pylori Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 4. Global Helicobacter Pylori Diagnostics Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Invasive Techniques Picture
Figure 8. Non-invasive Techniques Picture
Figure 9. Global Helicobacter Pylori Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 10. Global Helicobacter Pylori Diagnostics Sales Value Share 2019 VS 2023 VS 2030
Figure 11. Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2019-2030)
Figure 12. Hospitals and Clinics Picture
Figure 13. Diagnostic Laboratories Picture
Figure 14. Others Picture
Figure 15. Global Helicobacter Pylori Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Helicobacter Pylori Diagnostics Sales Value Share 2019 VS 2023 VS 2030
Figure 17. Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2019-2030)
Figure 18. Global Helicobacter Pylori Diagnostics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 19. Global Helicobacter Pylori Diagnostics Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 20. North America Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 22. Europe Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 24. Asia-Pacific Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia-Pacific Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 26. Latin America Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 27. Latin America Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 30. USA Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 31. USA Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 32. USA Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 33. Canada Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 34. Canada Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 35. Canada Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 36. Germany Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 37. Germany Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 38. Germany Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 39. France Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. France Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. France Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. U.K. Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. U.K. Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. U.K. Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Italy Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Italy Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Italy Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. Netherlands Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. Netherlands Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. Netherlands Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. Nordic Countries Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Nordic Countries Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. Nordic Countries Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. China Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. China Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. China Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Japan Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Japan Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Japan Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. South Korea Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. South Korea Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. South Korea Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. Southeast Asia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. Southeast Asia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. Southeast Asia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. India Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. India Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. India Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. Australia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. Australia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. Australia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Mexico Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Mexico Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Mexico Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. Brazil Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. Brazil Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. Brazil Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Turkey Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Turkey Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Turkey Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. UAE Helicobacter Pylori Diagnostics
Figure 1. Helicobacter Pylori Diagnostics Product Picture
Figure 2. Global Helicobacter Pylori Diagnostics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Helicobacter Pylori Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 4. Global Helicobacter Pylori Diagnostics Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Invasive Techniques Picture
Figure 8. Non-invasive Techniques Picture
Figure 9. Global Helicobacter Pylori Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 10. Global Helicobacter Pylori Diagnostics Sales Value Share 2019 VS 2023 VS 2030
Figure 11. Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2019-2030)
Figure 12. Hospitals and Clinics Picture
Figure 13. Diagnostic Laboratories Picture
Figure 14. Others Picture
Figure 15. Global Helicobacter Pylori Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Helicobacter Pylori Diagnostics Sales Value Share 2019 VS 2023 VS 2030
Figure 17. Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2019-2030)
Figure 18. Global Helicobacter Pylori Diagnostics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 19. Global Helicobacter Pylori Diagnostics Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 20. North America Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 22. Europe Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 24. Asia-Pacific Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia-Pacific Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 26. Latin America Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 27. Latin America Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Helicobacter Pylori Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 30. USA Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 31. USA Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 32. USA Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 33. Canada Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 34. Canada Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 35. Canada Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 36. Germany Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 37. Germany Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 38. Germany Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 39. France Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. France Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. France Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. U.K. Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. U.K. Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. U.K. Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Italy Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Italy Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Italy Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. Netherlands Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. Netherlands Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. Netherlands Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. Nordic Countries Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Nordic Countries Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. Nordic Countries Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. China Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. China Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. China Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Japan Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Japan Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Japan Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. South Korea Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. South Korea Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. South Korea Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. Southeast Asia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. Southeast Asia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. Southeast Asia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. India Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. India Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. India Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. Australia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. Australia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. Australia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Mexico Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Mexico Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Mexico Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. Brazil Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. Brazil Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. Brazil Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Turkey Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Turkey Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Turkey Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. UAE Helicobacter Pylori Diagnostics
